Efficacy of early pegylated interferon alpha-2b monotherapy for acute hepatitis C in HIV-infected patients.
De Rosa
Francesco G
FG
Mollaretti
Oscar
O
Audagnotto
Sabrina
S
De Blasi
Tiziano
T
Cariti
Giuseppe
G
Marucco
Diego M Aguilar
DM
Bonora
Stefano
S
Perri
Giovanni Di
GD
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D016896:Treatment Outcome; D055815:Young Adult
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b